Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery.

作者: Yoichi Naritomi , Seigo Sanoh , Shigeru Ohta

DOI: 10.1016/J.DMPK.2017.11.001

关键词: Prediction methodsHepatic microsomeDrug metabolismDrug discoveryMetaboliteBiologyPharmacokineticsPharmacologyDrug metabolizing enzymes

摘要: Abstract Predicting human drug metabolism and pharmacokinetics (PK) is key to discovery. In particular, it important predict PK, metabolite profiles drug-drug interactions (DDIs). Various methods have been used for such predictions, including in vitro metabolic studies using biological samples, as hepatic microsomes hepatocytes, in vivo experimental animals. However, prediction these are often inconclusive due discrepancies between results, interspecies differences in metabolism. Further, the changed from qualitative quantitative solve issues. Chimeric mice with humanized liver developed, which mouse cells mostly replaced hepatocytes. Since metabolizing enzymes expressed of mice, they regarded suitable models mimicking PK observed humans; therefore, useful predicting PK. this review, we discuss current state, issues, future directions chimeric

参考文章(61)
Seigo Sanoh, Shigeru Ohta, Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics Biopharmaceutics & Drug Disposition. ,vol. 35, pp. 71- 86 ,(2014) , 10.1002/BDD.1864
David F. Mercer, Daniel E. Schiller, John F. Elliott, Donna N. Douglas, Chunhai Hao, Aline Rinfret, William R. Addison, Karl P. Fischer, Thomas A. Churchill, Jonathan R.T. Lakey, David L.J. Tyrrell, Norman M. Kneteman, Hepatitis C virus replication in mice with chimeric human livers Nature Medicine. ,vol. 7, pp. 927- 933 ,(2001) , 10.1038/90968
Dan Xu, Gary Peltz, Can Humanized Mice Predict Drug “Behavior” in Humans? Annual Review of Pharmacology and Toxicology. ,vol. 56, pp. 323- 338 ,(2016) , 10.1146/ANNUREV-PHARMTOX-010715-103644
Naoyuki Nakada, Akio Kawamura, Hidetaka Kamimura, Koya Sato, Yasuhiro Kazuki, Masakazu Kakuni, Masato Ohbuchi, Kota Kato, Chise Tateno, Mitsuo Oshimura, Takashi Usui, MurineCyp3aknockout chimeric mice with humanized liver: prediction of the metabolic profile of nefazodone in humans Biopharmaceutics & Drug Disposition. ,vol. 37, pp. 3- 14 ,(2016) , 10.1002/BDD.1990
T.H. Lave, S. Dupin, C. Schmitt, R.C. Chou, D. Jaeck, Ph. Coassolo, Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. Journal of Pharmaceutical Sciences. ,vol. 86, pp. 584- 590 ,(1997) , 10.1021/JS960440H
Masami Hasegawa, Kenji Kawai, Tetsuya Mitsui, Kenji Taniguchi, Makoto Monnai, Masatoshi Wakui, Mamoru Ito, Makoto Suematsu, Gary Peltz, Masato Nakamura, Hiroshi Suemizu, The reconstituted ‘humanized liver’ in TK-NOG mice is mature and functional Biochemical and Biophysical Research Communications. ,vol. 405, pp. 405- 410 ,(2011) , 10.1016/J.BBRC.2011.01.042
Odette A Fahmi, Sharon L Ripp, Evaluation of models for predicting drug-drug interactions due to induction Expert Opinion on Drug Metabolism & Toxicology. ,vol. 6, pp. 1399- 1416 ,(2010) , 10.1517/17425255.2010.516251
Hiroyuki Kusuhara, Yuichi Sugiyama, In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. Drug Metabolism and Pharmacokinetics. ,vol. 24, pp. 37- 52 ,(2009) , 10.2133/DMPK.24.37